Caw-it, Reycel P.

HRN: 21-53-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2022
MUPIROCIN 2%, 15G (TUBE)
07/12/2022
07/17/2022
TOPICAL
Adequate Amount On Abrasions
Q12
Abrasions
Waiting Final Action 
07/12/2022
CEFUROXIME 750MG (VIAL)
07/12/2022
07/19/2022
IVT
750mg
Q8
Fracture Close Complete Displaced D3rd Femur R
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: